Niche-targeted therapy via YAP/TAZ activation enhances hematopoietic regeneration.

Activation of YAP/TAZ in bone marrow niche cells accelerates hematopoietic regeneration after myeloablative stress.

• Why it matters: Hematopoietic recovery is impaired by disruption of the bone marrow niche components, and current therapeutic options for niche restoration are limited, highlighting a need for targeted strategies.
• What they did: The study used pharmacological activation of YAP/TAZ to demonstrate their rapid activation in MSCs and ECs after injury, showing that this promotes niche recovery and supports hematopoietic regeneration.
• The result: YAP/TAZ activation enhances BM niche reorganization and hematopoietic regeneration, suggesting these factors as central regulators and potential targets for therapies to improve hematopoietic recovery.